Girijesh Kumar Patel

5PUBLICATIONS
8CO-AUTHORS
Cancer diagnosisMolecular targetsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 27, 2026
Next-Generation In Vitro Pulmonary Platforms for Respiratory Disease Modelling and Therapeutic Development: Current Advances and Future Prospects.

|Dec 20, 2024
A TBX2-driven signaling switch from androgen receptor to glucocorticoid receptor confers therapeutic resistance in prostate cancer.

Sayanika Dutta, Hamed Khedmatgozar, Girijesh Kumar Patel

|Sep 28, 2021
Helicobacter pylori-Induced Inflammation: Possible Factors Modulating the Risk of Gastric Cancer.

Sushil Kumar, Girijesh Kumar Patel, Uday C Ghoshal

|Feb 20, 2021
The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens.

Moh'd Khushman, Girijesh Kumar Patel, Anu Singh Maharjan

|May 03, 2020
Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer.

Mohammad Aslam Khan, Sanjeev Kumar Srivastava, Haseeb Zubair

Pageof 1

Frequent Collaborators

2 joint publications

Moh'd Khushman

1 joint publications

Gregory Stephen Gorman

1 joint publications

Ajay Pratap Singh

1 joint publications

Uday C Ghoshal